Literature DB >> 8227439

Increased pentane and carbon disulfide in the breath of patients with schizophrenia.

M Phillips1, M Sabas, J Greenberg.   

Abstract

AIMS: To determine the concentrations of pentane (a marker of lipid peroxidation) and other volatile organic compounds in the breath of patients with schizophrenia.
METHODS: Volatile organic compounds were assayed by gas chromatography/mass spectroscopy (GC/MS) in 88 subjects--25 with acute schizophrenic psychosis, 26 with psychiatric disorders other than schizophrenia, and 37 normal volunteers.
RESULTS: The mean alveolar gradients of pentane and carbon disulfide (CS2) were significantly higher in the patients with schizophrenia than in the control groups.
CONCLUSIONS: Schizophrenia may be accompanied by accelerated lipid peroxidation in cell membranes, as well as increased manufacture of CS2, a known neurotoxin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227439      PMCID: PMC501526          DOI: 10.1136/jcp.46.9.861

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Breath tests in medicine.

Authors:  M Phillips
Journal:  Sci Am       Date:  1992-07       Impact factor: 2.142

2.  [Study of the processes of lipid peroxidation in patients with endogenous psychoses using gas chromatography].

Authors:  E S Kovaleva; O N Orlov; E D Bogdanova; B S Beliaev; M Ia Tsutsul'kovskaia
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1989

Review 3.  Carbon disulfide poisoning: a review.

Authors:  M Davidson; M Feinleib
Journal:  Am Heart J       Date:  1972-01       Impact factor: 4.749

4.  Toxicity of carbon disulphide.

Authors:  L Magos
Journal:  Ann Occup Hyg       Date:  1972-11

5.  Volatile fatty acids in the breath of patients with cirrhosis of the liver.

Authors:  S Chen; V Mahadevan; L Zieve
Journal:  J Lab Clin Med       Date:  1970-04

6.  Mercaptans and dimethyl sulfide in the breath of patients with cirrhosis of the liver. Effect of feeding methionine.

Authors:  S Chen; L Zieve; V Mahadevan
Journal:  J Lab Clin Med       Date:  1970-04

Review 7.  A critical review of the literature on carbon disulfide toxicity.

Authors:  R O Beauchamp; J S Bus; J A Popp; C J Boreiko; L Goldberg
Journal:  Crit Rev Toxicol       Date:  1983       Impact factor: 5.635

8.  Evaluation of volatile sulfur compounds in the expired alveolar gas in patients with liver cirrhosis.

Authors:  H Kaji; M Hisamura; N Saito; M Murao
Journal:  Clin Chim Acta       Date:  1978-05-02       Impact factor: 3.786

9.  Development of a method to monitor low molecular mass hydrocarbons in exhaled breath of man: preliminary evaluation of its interest for detecting a lipoperoxidation process in vivo.

Authors:  P Hotz; P Hoet; R Lauwerys; J P Buchet
Journal:  Clin Chim Acta       Date:  1987-02-15       Impact factor: 3.786

10.  Breath pentane excretion as a marker of disease activity in rheumatoid arthritis.

Authors:  S Humad; E Zarling; M Clapper; J L Skosey
Journal:  Free Radic Res Commun       Date:  1988
View more
  23 in total

Review 1.  Advances in electronic-nose technologies developed for biomedical applications.

Authors:  Alphus D Wilson; Manuela Baietto
Journal:  Sensors (Basel)       Date:  2011-01-19       Impact factor: 3.576

2.  Fatty acids and schizophrenia.

Authors:  J D Laugharne; J E Mellor; M Peet
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 3.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

Review 4.  Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

Authors:  J K Yao; R D Reddy; D P van Kammen
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Metabolic and environmental origins of volatile organic compounds in breath.

Authors:  M Phillips; J Greenberg; J Awad
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

6.  Correlation of breath ammonia with blood urea nitrogen and creatinine during hemodialysis.

Authors:  L R Narasimhan; W Goodman; C K Patel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

7.  Volatile organic compounds in the breath of patients with schizophrenia.

Authors:  M Phillips; G A Erickson; M Sabas; J P Smith; J Greenberg
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

8.  Colorectal cancer screening with odour material by canine scent detection.

Authors:  Hideto Sonoda; Shunji Kohnoe; Tetsuro Yamazato; Yuji Satoh; Gouki Morizono; Kentaro Shikata; Makoto Morita; Akihiro Watanabe; Masaru Morita; Yoshihiro Kakeji; Fumio Inoue; Yoshihiko Maehara
Journal:  Gut       Date:  2011-01-31       Impact factor: 23.059

9.  Breath analysis using laser spectroscopic techniques: breath biomarkers, spectral fingerprints, and detection limits.

Authors:  Chuji Wang; Peeyush Sahay
Journal:  Sensors (Basel)       Date:  2009-10-19       Impact factor: 3.576

10.  Investigation of volatile organic biomarkers derived from Plasmodium falciparum in vitro.

Authors:  Rina P M Wong; Gavin R Flematti; Timothy M E Davis
Journal:  Malar J       Date:  2012-09-07       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.